Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

179
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
179
Stages of Infection01:26

Stages of Infection

56.3K
Stages of infection describe what happens to a susceptible host once a pathogen invades the human body. The stages of infection are incubation, prodromal, illness, stage of decline, and convalescence. The incubation stage is the period from exposure to a pathogen until symptoms start. The infected person is unaware of impending illness as the pathogens grow and multiply within the body. The duration may vary depending on the type of infection. The incubation period of measles averages ten to...
56.3K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

267
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
267
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

198
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
198
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

166
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
166
  1. Home
  3. Median Duration And Factors That Influence The Duration Of Symptom Resolution In Covid-19 Patients In Ethiopia: A Follow-up Study Involving Symptomatic Cases.
  1. Home
  3. Median Duration And Factors That Influence The Duration Of Symptom Resolution In Covid-19 Patients In Ethiopia: A Follow-up Study Involving Symptomatic Cases.

Related Experiment Video

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

2.3K

Median duration and factors that influence the duration of symptom resolution in COVID-19 patients in Ethiopia: A

Saro Abdella Abrahim1, Masresha Tessema1, Eshetu Ejeta1

  • 1Ethiopian Public Health Institute Addis Ababa Ethiopia.

Lifestyle Medicine (Hoboken, N.J.)
|April 12, 2024

View abstract on PubMed

Summary
This summary is machine-generated.
Keywords:
COVID‐19durationsymptom

More Related Videos

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
04:03

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD

Published on: September 27, 2024

666
Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
09:03

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic

Published on: November 7, 2020

4.8K

Related Experiment Videos

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

2.3K
Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
04:03

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD

Published on: September 27, 2024

666
Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
09:03

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic

Published on: November 7, 2020

4.8K

The median duration for COVID-19 symptom resolution is seven days. Male sex and higher body mass index (BMI) predict delayed recovery, informing public health strategies for infectious disease management.

Area of Science:

  • Infectious Diseases
  • Epidemiology
  • Public Health

Background:

  • Understanding COVID-19 clinical course is vital for effective public health interventions.
  • Symptom resolution duration is a key metric for patient isolation and policy development.
  • Ethiopian context for COVID-19 symptom duration requires specific investigation.

Purpose of the Study:

  • To determine the median duration of symptom resolution in COVID-19 patients in Ethiopia.
  • To identify predictors of delayed symptom resolution among symptomatic COVID-19 cases.
  • To inform public health strategies based on clinical recovery timelines.

Main Methods:

  • Prospective cohort study at a dedicated COVID-19 treatment center.
  • Inclusion of 124 symptomatic adult COVID-19 patients.
  • Cox proportional-hazards regression analysis to identify predictors.

    • Main Results:

    • Median symptom resolution time for COVID-19 was seven days.
    • Male sex was associated with a 55% higher hazard of delayed resolution.
    • Body Mass Index (BMI) ≥ 25 kg/m² increased the hazard of delayed resolution by 35%.

    Conclusions:

    • COVID-19 symptom resolution averages seven days.
    • Male gender and elevated BMI are significant predictors of prolonged recovery.
    • Public health planning should account for these factors in isolation and shielding strategies.